CPT only copyright 2011 American Medical Association. Page 2 of 5 What You Need to Know This article explains the difference between a National Provider Identifier (NPI) and a Provider Transaction Access Number (PTAN). There are no policy changes in this article.
For people with aggressive B cell non-Hodgkin lymphoma, we commonly recommend a chemotherapy treatment called R-CHOP. It is named after the medicines included in the mixture: rituximab (RituxanÂ®), a monoclonal antibody that helps your immune system destroy the cancer cells and makes the chemotherapy more powerful
Technical considerations for the use of radiation therapy to treat Hodgkin lymphoma include the following: 1  A linear accelerator with a beam energy of 6 mV is desirable because of its penetration, well-defined edge, and homogeneity throughout an irregular treatment field.